MD862G2 - Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei - Google Patents
Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozeiInfo
- Publication number
- MD862G2 MD862G2 MD97-0168A MD970168A MD862G2 MD 862 G2 MD862 G2 MD 862G2 MD 970168 A MD970168 A MD 970168A MD 862 G2 MD862 G2 MD 862G2
- Authority
- MD
- Moldova
- Prior art keywords
- dislipidemy
- remedy
- atherosclerosis treatment
- pectine
- increasing
- Prior art date
Links
- 201000001320 Atherosclerosis Diseases 0.000 title abstract 2
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 abstract 2
- 230000000871 hypocholesterolemic effect Effects 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- -1 calcium cations Chemical class 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000006266 etherification reaction Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Invenţia se referă la medicină, în special, la cardiologie.Esenţa invenţiei constă în aceea că remediul pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei pe bază de polizaharide include pectină cu un grad de eterificare mai înalt de 70%, cu efect hipocolesterolemic, ce conţine cationi de calciu în cantitate de 300-500 mg-echiv./kg, în special pectină de măr.Rezultatul tehnic al invenţiei constă în creşterea proprietăţilor hipocolesterolemice cu reducerea trigliceridelor şi majorarea nivelului de C-HDL.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD97-0168A MD862G2 (ro) | 1997-06-23 | 1997-06-23 | Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD97-0168A MD862G2 (ro) | 1997-06-23 | 1997-06-23 | Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD862F1 MD862F1 (ro) | 1997-10-31 |
| MD862G2 true MD862G2 (ro) | 1998-07-31 |
Family
ID=19739022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD97-0168A MD862G2 (ro) | 1997-06-23 | 1997-06-23 | Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD862G2 (ro) |
-
1997
- 1997-06-23 MD MD97-0168A patent/MD862G2/ro not_active IP Right Cessation
Non-Patent Citations (2)
| Title |
|---|
| A.S. Truswell. " Dietary Fibre and Plasma Lipids: Potential for Prevention and Treatment of Hyperlipidaemias.Dietary Fibre-A component of food.1993.p.295-348. * |
| Cs. gastroenterologie, V.37,N1, E. Ginter, R. Kohn, A. Malovicova et al. " Zavislost. Hipolipemickeno ucinki pectinov na ich chemickom Zlozeni", p.37-46. * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD862F1 (ro) | 1997-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9901674A0 (en) | Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders. | |
| MX9700223A (es) | Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida. | |
| BG102726A (en) | Combined therapy for osteoporosis | |
| BG105556A (en) | New esters derived from substituted phenyl-cyclohexyl compounds | |
| GR970300016T1 (en) | Lactobacillus strains of human origin, their compositions and uses thereof | |
| IL214607A0 (en) | 2,4-pyrimidinedinediamine compounds and their use in the manufacture of medicaments for the treatment of autoimmune disases | |
| BG104943A (en) | Biodegradable sustained-release alginate gels | |
| ZA200110504B (en) | Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria. | |
| ES2191174T3 (es) | (-)hidroxicitrato de magnesio, procedimiento de preparacion, aplicaciones y composiciones principalmente farmaceuticas que lo contienen. | |
| MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
| AU3259099A (en) | Pharmaceutical composition based on natural synthesis progesterone and oestradiol and preparation method | |
| MXPA04002565A (es) | Combinacion de un inhibidor de il-1/18 con un inhibidor de tnf para el tratamiento de inflamacion. | |
| PL340561A1 (en) | Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders | |
| EP0606903A3 (en) | Interconnects. | |
| ZA948B (en) | Endothelin converting enzyme inhibitors | |
| SI0951909T1 (en) | Combination composition comprising a L-carnitine or an alkanoyl-L-carnitine, a glycosaminoglycan and/or constituent thereof | |
| EP0940316A3 (en) | Drawer tower | |
| BG105256A (en) | Muscarinic agonists and antagonists | |
| AU4830097A (en) | Use of an extract of Cimicifuga | |
| EP0615728A3 (en) | Orthopedic reconstruction plate. | |
| EP1275379A3 (en) | Basic granulate comprising (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | |
| BR9812368A (pt) | 2-aminotetralinas, processo para sua preparação, e composições farmacêuticas, para a prevenção e tratamento terapêutico de patologias inflamatórias e/ou autoimunes | |
| AU6849198A (en) | Neurotrypsin | |
| BG104292A (en) | Methods and compositions for the treatment of rheumatoid arthritis | |
| NZ525536A (en) | Treatment of arthritis and other similar conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Granted patent for invention | ||
| IF99 | Valid patent on 19990615 |
Free format text: EXPIRES: 20170623 |
|
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |